BioSpace News Archive

Cleave Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on VCP/p97 as a novel target in oncology, announced that it has entered into a preclinical research collaboration with Jazz Pharmaceuticals, a global biopharmaceutical company developing life-changing medicines for people with serious diseases. Under the terms of the a

Cerus Corporation (Nasdaq:CERS) announced today that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, and Kevin D. Green, Cerus’ chief financial officer, are scheduled to participate in the following two conferences: The Cantor Fitzgerald Virtual Global Healthcare Conference on Tuesday, September 15 th at 2:00 P.M. ET. The H.C. Wainwright 22 nd Annual Global Investment Conference on

Trinity Life Sciences, a leader in global life sciences solutions, introduces Trinity CloudCast™, the revolutionary connected forecast modeling and management tool that fully leverages Microsoft® Excel®.

Effort points to the vital importance of vision research, how it is improving sight and broader health and well-being

American BriVision (Holding) Corporation (OTCQB: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today issued a full clinical study report (CSR) of Vitargus® First-in-Human Phase I Clinical Trial . The safety and preliminary efficacy findings from this study, combined with the unique properties of Vitargus® (BFC-1401), are supportive of further

The Muscular Dystrophy Association announced the relaunch of their legendary Jerry Lewis MDA Telethon with Kevin Hart joining as host.

Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat pulmonary disease, today announced that a live case featuring its RheOx ™ Bronchial Rheoplasty System was performed during the virtual European Respiratory Society (ERS) International Congress 2020.

GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, announced today the company has initiated large-scale manufacturing of its first-in-class recombinant hyperimmune drug for COVID-19, GIGA-2050, in collaboration with two partners for Good Manufacturing Practice (GMP), Waisman Biomanufacturing and Goodwin Biotechnology, Inc.

Hogan Assessments, Spectrum Fusion, and Fast Forward Analytics have teamed up to identify the strengths and skills of adults on the autism spectrum and create innovative solutions to bring their talents to the workplace and build a neurodiverse workforce

M400s being used to stream patient surgeries for up to 16 hours for education and training purposes